Brind.
  1. Illumina announced an agreement to acquire SomaLogic on September 3, 2025, utilizing SomaLogic's technology for new assays.

Illumina acquired SomaLogic for cash and royalties.

2 reports, 1 independent Updated Aug 12
Gone quiet
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Illumina acquired SomaLogic for cash and royalties.

Who's involved

What this event is mainly about
IlluminaSomaLogic

How it developed

Newest first. Tap a step to see who reported it.
  1. Standard BioTools acquired SomaLogic, retaining reagent rights for Illumina, following a strategic sale of SomaLogic to Illumina.Sub-event
  2. The acquisition of SomaLogic by Illumina was completed in August 2025.1 source

Keep exploring

Part of

Illumina announced an agreement to acquire SomaLogic on September 3, 2025, utilizing SomaLogic's technology for new assays. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireStandard BioTools Reports Second Quarter 2025 Financial Results SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTool
  • Unknown outlet